Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Dexketoprofen Trometamol Oral Solution vs. Tablets
NCT02209454Phase 1Completed
- Sponsor
- Menarini Group
- Start
- Apr 2014
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dexketoprofen trometamol in acute pain (2 arms), sponsored by Menarini Group. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve from time zero to last measurable concentration. Started Apr 2014; status: completed.
02
Drugs
dexketoprofen trometamol
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02209454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209454.